ResMed reported $3.74B in Equity Capital and Reserves for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Ansell ANN:AU USD 1.54B 9.4M
Cochlear COH:AU AUD 1.69B 44.1M
CSL CSL:AU USD 14.58B 544.3M
Estia Health EHE:AU AUD 541.74M 56.16M
Fisher & Paykel Healthcare FPH:AU NZD 1.48B 201.3M
Healius Ltd HLS:AU AUD 1.92B 15.7M
Integral Diagnostics Ltd IDX:AU AUD 347.24M 80.25M
Mayne Pharma MYX:AU AUD 564.77M 180.98M
Nanosonics Ltd NAN:AU AUD 138.69M 1.45M
Opthea Ltd OPT:AU USD 47.98M 52.3M
Polynovo Ltd PNV:AU AUD 17.72M 2.35M
Ramsay Health Care RHC:AU AUD 3.93B 24.8M
Regis Healthcare REG:AU AUD 79.01M 45.45M
ResMed RMD:AU USD 3.74B 377.38M
Sigma Healthcare Ltd SIG:AU AUD 476.84M 10.35M
Sonic Healthcare SHL:AU AUD 7.27B 219.28M
Telix Pharmaceuticals Ltd TLX:AU AUD 105.41M 103.25M